You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 15, 2024

Sulfacetamide sodium - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for sulfacetamide sodium and what is the scope of freedom to operate?

Sulfacetamide sodium is the generic ingredient in seventeen branded drugs marketed by Bausch, Fougera Pharms, Padagis Us, Taro, Allergan, Alcon, Schering, Pharmafair, Miza Pharms Usa, Epic Pharma Llc, Sola Barnes Hind, Novartis, Optopics, Akorn, Alcon Pharms Ltd, Bausch And Lomb, and Sandoz, and is included in thirty NDAs. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for sulfacetamide sodium. Eleven suppliers are listed for this compound.

Summary for sulfacetamide sodium
Recent Clinical Trials for sulfacetamide sodium

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Sidney Kimmel Cancer Center at Thomas Jefferson UniversityN/A

See all sulfacetamide sodium clinical trials

Pharmacology for sulfacetamide sodium
Medical Subject Heading (MeSH) Categories for sulfacetamide sodium

US Patents and Regulatory Information for sulfacetamide sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alcon ISOPTO CETAMIDE sulfacetamide sodium SOLUTION/DROPS;OPHTHALMIC 080020-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Schering SODIUM SULAMYD sulfacetamide sodium SOLUTION/DROPS;OPHTHALMIC 005963-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Novartis SULF-10 sulfacetamide sodium SOLUTION/DROPS;OPHTHALMIC 080025-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Sola Barnes Hind SODIUM SULFACETAMIDE sulfacetamide sodium SOLUTION/DROPS;OPHTHALMIC 084145-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.